What Researchers Did
This review article summarized the causes, symptoms, and current and emerging treatments for painful diabetic neuropathy.
What They Found
Approximately 50% of diabetic patients develop peripheral neuropathy within 25 years. Current therapies, including tricyclic antidepressants, selective norepinephrine reuptake inhibitors, pregabalin, gabapentin, and lamotrigine, primarily aim to provide symptomatic relief. Newer treatments under study for painful diabetic neuropathy include hyperbaric oxygen, NMDA antagonists, and alpha lipoic acid.
What This Means for Canadian Patients
Canadian patients suffering from painful diabetic neuropathy often experience severe burning or stabbing pain, significantly impacting their quality of life. While current treatments focus on managing symptoms, this review highlights potential future options like hyperbaric oxygen therapy that could offer new avenues for pain relief and disease management.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This review notes that hyperbaric oxygen is still a newer therapy under study for painful diabetic neuropathy, indicating its effectiveness for this specific condition is not yet fully established.